Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 137,898Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Amgen Switzerland Ag

02 5Amgen Technology (Ireland) Unlimited Company

03 2Aryogen Pharmed

04 4Biosimilar Collaborations Ireland Limited

05 3Celltrion Healthcare Hungary Kft

06 6Celltrion Healthcare Hungary Kft.

07 2Centus Biotherapeutics Europe Limited

08 2F.Hoffmann-La Roche Ltd

09 3Fgk Representative Service Gmbh

10 2Iqone Healthcare Switzerland Sa

11 1Mabixience Research Sl

12 2Mabxience Research SL

13 3Mabxience Research Sl

14 1Mylan Ire Healthcare Ltd

15 3Outlook Therapeutics Limited

16 2Pfizer Ag

17 2Pfizer Europe MA EEIG

18 5Pfizer Europe Ma Eeig

19 2ROCHE REGISTRATION LTD

20 2Roche Pharma (Switzerland) Ag

21 2Roche Registration GmbH

22 6Roche Registration Gmbh

23 2Samsung Bioepis NL BV

24 5Samsung Bioepis Nl B.V.

25 1Samsung Bioepis Nl Bv

26 2Spirig Healthcare Ag

27 2Stada Arzneimittel Ag

28 2Stada Pharmaceuticals Ag

29 2Teva Pharma Ag

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Bevacizumabum

Brand Name : MVASI

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 100mg/4ml

Packaging :

Approval Date : 09/12/2019

Application Number : 67283

Regulatory Info : Allowed

Registration Country : Switzerland

blank

02

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Bevacizumabum

Brand Name : MVASI

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 400mg/16ml

Packaging :

Approval Date : 09/12/2019

Application Number : 67283

Regulatory Info : Allowed

Registration Country : Switzerland

blank

03

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Bevacizumab

Brand Name : Mvasi

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 25mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

04

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Bevacizumab

Brand Name : Mvasi

Dosage Form : Concentrate For Infusion Solution

Dosage Strength : 25MG

Packaging :

Approval Date : 27-09-2019

Application Number : 1171246001

Regulatory Info : Authorized

Registration Country : Spain

blank

05

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Bevacizumab

Brand Name : Mvasi

Dosage Form : Concentrate For Infusion Solution

Dosage Strength : 25MG

Packaging :

Approval Date : 27-09-2019

Application Number : 1171246002

Regulatory Info : Authorized

Registration Country : Spain

blank

06

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Bevacizumab

Brand Name : Mvasi

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 25mg/ml

Packaging :

Approval Date : 15-01-2018

Application Number : 28105882916

Regulatory Info : Prescription

Registration Country : Denmark

blank

07

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Bevacizumab

Brand Name : Mvasi

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 25mg/ml

Packaging :

Approval Date : 15-01-2018

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

08

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Bevacizumab

Brand Name : Stivant

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 25mg/ml

Packaging :

Approval Date : 31-07-2024

Application Number :

Regulatory Info :

Registration Country : Moldova

blank

09

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Bevacizumab

Brand Name : Stivant

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 25mg/ml

Packaging :

Approval Date : 31-07-2024

Application Number :

Regulatory Info :

Registration Country : Moldova

blank

10

Biosimilar Collaborations Ireland Limite...

Country
Health 2.0 Conference
Not Confirmed
arrow

Biosimilar Collaborations Ireland Limite...

Country
arrow
Health 2.0 Conference
Not Confirmed

Bevacizumab

Brand Name : Abevmy

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 25mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank